SAFC opens $30M API facility

Sigma-Aldrich company SAFC has opened a $30-million expansion to its Madison Manufacturing facility in Verona, WI. The facility increases custom manufacturer's capacity to produce high-potency active pharmaceutical ingredients.

The 51,000 square-foot expansion complements the company's existing 63,000 square-foot facility. The addition houses commercial-scale reactors capable of batch sizes to 4,000 liters, a 10x capacity increase over the older plant.

The new space caters to drug manufacturers involved with Phase III and commercial high-potency API needs. It features Safebridge design and containment engineering, and adheres to Category IV standards, the highest for high-potency API handling and containment. The facility includes a 150-liter mini-processing plant and two large-scale cGMP manufacturing suites.

With the expansion, SAFC is growing its presence among a growing number of high-potency API suppliers. As we've reported, Compass Pharma Services, Helsinn and DSM Pharmaceuticals are among those who have made high-potency manufacturing facility and certification announcements in the last year.

- take a look at Sigma-Aldrich's announcement

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.